UBS Investment Bank has announced a coupon payment for the ETRACS Alerian MLP Index ETN Series B (AMUB), which is traded on NYSE Arca.
ETRACS ETNs are senior unsecured notes issued by UBS AG. These notes are available for trading on either NYSE Arca or NASDAQ and can be bought or sold through brokers or financial advisors. UBS highlights that investing in ETRACS ETNs involves certain risks, including the potential loss of principal and dependence on the creditworthiness of UBS AG. The company advises investors to review the “Risk Factors” detailed in the relevant prospectus supplement before making investment decisions.
A registration statement related to these securities offerings has been filed with the Securities and Exchange Commission (SEC). Investors are encouraged to read the prospectus, applicable supplements, and pricing documents before investing. These documents can be accessed without cost through EDGAR at the SEC’s website (http://www.sec.gov) or requested by phone.
UBS is headquartered in Zurich, Switzerland, and operates in more than 50 markets worldwide. As of the fourth quarter of 2024, UBS managed $6.1 trillion in invested assets. The firm provides wealth management, asset management solutions, and investment banking services globally. Its shares are listed on both SIX Swiss Exchange and New York Stock Exchange.
In the United States, securities activities such as underwriting, trading, brokerage, and M&A advisory services are provided by UBS Securities LLC—a wholly owned subsidiary of UBS AG—and by UBS Financial Services Inc., both registered broker/dealers.
According to UBS: "This material is issued by UBS AG and/or any of its subsidiaries and/or any of its affiliates ("UBS"). This document was produced by and the opinions expressed are those of UBS as of the date of writing and are subject to change. It has been prepared solely for information purposes and for the use of the recipient. It does not constitute an offer or an invitation by or on behalf of UBS to any person to buy or sell any security."
The Alerian MLP Index and AMZ trademarks referenced in connection with AMUB belong to VettaFi under license from VettaFi.
For further information regarding this announcement, media inquiries can be directed to Carolyn Reil at +1-212-713-3584 or carolyn.reil@ubs.com.